ARTICLE | Clinical News
Lidakol n-docosanol 10 percent cream: LDAKA began one of two Phase III trials
August 5, 1996 7:00 AM UTC
Lidak Pharmaceuticals (LDAKA), La Jolla, Calif. Product: Lidakol n-docosanol 10 percent cream Indication: Recurrent oral herpes (cold sores) Status: LDAKA began one of two Phase III trials, with the s...